• Claes Örvell
Part of the Infectious Agents and Pathogenesis book series (IAPA)


Paramyxoviruses may cause an involvement of the central nervous system (CNS) during infection of the natural host as well as in experimental infection of laboratory animals.1 These viruses may invade the CNS during the clinical or subclinical acute stage of the infection. When the virus is not effectively eliminated by the immune response, it may persist in the CNS in a clinically silent phase for variable periods of time. After the silent phase the virus may cause symptoms attributable to cerebral dysfunction; serious disease and even death of the host may follow.


Newcastle Disease Virus Viral Antigen Measle Virus Canine Distemper Virus Mumps Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kristensson, K., and Norrby, E., 1986, Persistence of RNA viruses in the central nervous system, Annu. Rev. Microbiol. 40: 159–184.Google Scholar
  2. 2.
    Örvell, C., and Norrby, E., 1985, Antigenic structure of paramyxoviruses, in: Immunochemistry of Viruses—the Basis for Serodiagnosis and Vaccines ( A. R. Neurath and M. H. V. van Regenmortel, eds.), Elsevier, Amsterdam, pp. 241–264.Google Scholar
  3. 3.
    Örvell, C., and Norrby, E., 1980, Immunological relationships between homologous structural polypeptides of measles and canine distemper virus, J. Gen. Virol. 50: 231–245.PubMedGoogle Scholar
  4. 4.
    Sheshberadaran, H., Norrby, E., McCullough, K. C., Carpenter, W C., and Örvell, C., 1986, The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies, J. Gen. Virol. 67: 1381–1392.PubMedGoogle Scholar
  5. 5.
    Cosby, S. L., McQuaid, S., Duffu, N., Lyons, C., Rima, B. K., Allan, G. M., McCullough, S. J., Kennedy, S., Smyth, J. A., McNeilly, E, Craig, C., and Örvell, C., 1988, Characterization of a seal morbillivirus, Nature 336: 115–116.Google Scholar
  6. 6.
    Mufson, M. A., Örvell, C., Rafnar, B., and Norrby, E., 1985, Two distinct subtypes of human respiratory syncytial (RS) virus of different epidemiological occurrence, J. Gen. Virol. 66: 2111–2124.PubMedGoogle Scholar
  7. 7.
    Lerch, R. A., Stott, E. J., and Wertz, G. W, 1989, Characterization of bovine respiratory syncytial virus proteins and mRNAs and generation of cDNA clones to the viral mRNAs, Virol. 63: 833–840.Google Scholar
  8. 8.
    Ling, R., and Pringle, C. R., 1989, Polypeptides of pneumonia virus of mice. I. Immunological cross-reactions and post-translational modifications, J. Gen. Virol. 70: 1427–1440.PubMedGoogle Scholar
  9. 9.
    Grandien, M., Örvell, C., and Norrby, E., 1988, Paramyxoviridae, in: Laboratory Diagnosis of Infectious Diseases. Principles and Practice, Volume II, Viral, Rickettsial and Chlamydial Diseases ( E. H. Lennette, P. Halonen, and E. A. Murphy, eds.), Springer Verlag, New York, pp. 484–539.Google Scholar
  10. 10.
    Örvell, C., 1984, The reactions of monoclonal antibodies with structural proteins of mumps virus, J Immunol. 132: 2622–2629.PubMedGoogle Scholar
  11. 11.
    Johnson, R. T., 1982, Viral Infections of the Central Nervous System, Raven Press, New York.Google Scholar
  12. 12.
    Axthelm, M. K., and Krakowa, S., 1987, Canine distemper virus: The early blood–brain lesion, Acta Neuropathol. (Berl.) 75:27–33.Google Scholar
  13. 13.
    Krakowa, S., Cork, L. C., Winkelstein, J. A., and Axthelm, M. K., 1987, Establishment of central nervous system infection by canine distemper virus: breach of the blood–brain barrier and facilitation by antiviral antibody, Vet. Immunol. Immunopathol. 17: 471–482.Google Scholar
  14. 14.
    Krakowa, S., Axthelm, M. K., and Gorham, J. R., 1987, Effects of induced thrombocytopenia on viral invasion of the central nervous system in canine distemper virus infection, J. Comp. Pathol. 97: 441–450.Google Scholar
  15. 15.
    Wolinsky, J. S., Klassen, T., and Baringer, J. R., 1976, Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation, J Infect. Dis. 133: 260–267.PubMedGoogle Scholar
  16. 16.
    Wolinsky, J. S., 1977, Mumps virus-induced hydrocephalus in hamsters. Ultrastructure of the chronic infection, Lab. Invest. 37: 229–235.PubMedGoogle Scholar
  17. 17.
    Duffy, P. E., Wolf, A., Harter, D. H., Gamboa, E. T., and Hsue, K. C., 1973, Murine influenza virus encephalomyelitis. II. Electron microscopic observations, j Neuropathol. Exp. Neurol. 32: 72–91.PubMedGoogle Scholar
  18. 18.
    Margolis, G., Kilham, L., and Baringer, J. R., 1974, A new look at mumps encephalitis: Inclusion bodies and cytopathic effects, J. Neuropathol. Exp. Neurol. 33: 13–28.PubMedGoogle Scholar
  19. 19.
    Wolinsky, J. S., Baringer, J. R., Margolis, G., and Kilham, L., 1974, Ultrastructure of mumps virus replication in newborn hamster central nervous system, Lab. Invest. 31: 403–412.PubMedGoogle Scholar
  20. 20.
    Löve, A., Rydbeck, R., Kristensson, K., Örvell, C., and Norrby, E., 1985, Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: Analysis of mutants selected with monoclonal antibodies, J. Virol. 53: 67–74.PubMedGoogle Scholar
  21. 21.
    Kövamees, J., Rydbeck, R., Örvell, C., and Norrby, E., 1990, Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus, Virus Res. 17: 119–130.PubMedGoogle Scholar
  22. 22.
    Roux, L., and Waldvogel, E. A., 1981, Establishment of Sendai virus persistent infection: Biochemical analysis of the early phase of standard plus defective interfering virus infection of BHK cells, Virology 112: 400–410.PubMedGoogle Scholar
  23. 23.
    Wechsler, S. L., Lambert, D. M., Galinski, M. S., Mink, M. A., Rochovansky, O., and Pons, M. W, 1987, Immediate persistent infection by human parainfluenza virus 3: Unique fusion properties of the persistently infected cells, J. Gen. Virol. 68: 1737–1748.PubMedGoogle Scholar
  24. 24.
    Rima, B. K., Davidson, W. B., and Martin, S. J., 1977, The role of defective interfering particles in persistent infection of Vero cells by measles virus, J. Gen. Virol. 35: 89–97.Google Scholar
  25. 25.
    Wild, T. E, Bernard, A., and Greenland, T., 1981, Measles virus: Evolution of a persistent infection in BGM cells, Arch. Virol. 67: 297–308.PubMedGoogle Scholar
  26. 26.
    Metzler, A. E., Krakowa, S., Axthelm, M. K., and Gorham, J. R., 1983, In vitro propagation of canine distemper virus: Establishment of persistent infection in Vero cells, Am. J. Vet. Res. 45: 2211–2215.Google Scholar
  27. 27.
    Cosby, S. L., Lyons, C., Rima, B. K., and Martin, S. J., 1985, The generation of small-plaque mutants during undiluted passage of canine distemper virus, Intervirology 23: 157–166.PubMedGoogle Scholar
  28. 28.
    Norrby, E., Chen, S. N., Togashi, T., Sheshberadaran, H., and Johnson, K. P., 1982, Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells, Arch. Virol. 71: 1–11.PubMedGoogle Scholar
  29. 29.
    Summers, B. A., Greissen, H. A., and Appel, M. J. G., 1984, Canine distemper encephalomyelitis: Variation with virus strain, J. Comp. Pathol. 94: 65–75.Google Scholar
  30. 30.
    Appel, M. G. J., Shek, W. R., and Summers, B. A., 1982, Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus, Infect. Immun. 37: 592–600.Google Scholar
  31. 31.
    Johnson, G. C., Krakowa, S., and Axthelm, M. K., 1987, Prolonged viral antigen retention in the brain of a gnotobiotic dog experimentally infected with canine distemper virus, Vet. Pathol. 24: 87–89.PubMedGoogle Scholar
  32. 32.
    Summers, B. A., Whitaker, J. N., and Appel, M. G. J., 1987, Demyelinating canine distemper encephalomyelitis: Measurement of myelin basic protein in cerebrospinal fluid, J. Neuroimmunol. 14: 227–233.PubMedGoogle Scholar
  33. 33.
    Wechsler, S. L., and Meissner, H. C., 1982, Measles and SSPE viruses Similarities and differences, Prog. Med. Virol. 28: 65–95.PubMedGoogle Scholar
  34. 34.
    ter Meulen, V., and Carter, M. J., 1984, Measles virus persistency and disease, Prog. Med. Virol. 30: 44–61.PubMedGoogle Scholar
  35. 35.
    Dyken, P. R., 1985, Subacute sclerosing panencephalitis. Current status, Neurol. Clin. 3: 179–196.PubMedGoogle Scholar
  36. 36.
    Johnson, K. P., and Norrby, E., 1974, Subacute sclerosing panencephalitis (SSPE) agent in hamsters. III. Induction of defective measles in hamster brain, Exp. Mol. Pathol. 21: 166–178.PubMedGoogle Scholar
  37. 37.
    Johnson, K. P., Norrby, E., Swoveland, P., and Carrigan, D. R., 1981, Experimental subacute sclerosing panencephalitis: Selective disappearance of measles virus matrix protein from the central nervous system, J. Infect. Dis. 144: 161–169.PubMedGoogle Scholar
  38. 38.
    Norrby, E., Kristensson, K., Brzosko, W. J., and Kaspenberg, J. A., 1985, Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis, J. Virol. 56: 337–340.Google Scholar
  39. 39.
    Liebert, U. G., Baczko, K., Budka, H., and ter Meulen, V, 1986, Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis, J. Gen. Virol. 67: 2435–2444.PubMedGoogle Scholar
  40. 40.
    Baczko, K., Liebert, U. G., Billeter, M., Cattaneo, R., Budka, H., and ter Meulen, V., 1986, Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis, J. Virol. 59: 472–478.PubMedGoogle Scholar
  41. 41.
    Baczko, K., Liebert, U. G., Caftan, R., Billeter, M. A., Roos, R. P., and ter Meulen, V., 1988, Restriction of measles virus gene expression in measles inclusion body encephalitis, J Infect. Dis. 158: 144–150.Google Scholar
  42. 42.
    Cattaneo, R., Rebmann, G., Baczko, K., ter Meulen, V., and Billeter, M. A., 1987, Altered ratios of measles virus transcripts in diseased human brains, Virology 160: 523–526.PubMedGoogle Scholar
  43. 43.
    Cattaneo, R., Schmid, A., Eschele, D., Baczko, K., ter Meulen, V, and Billeter, M. A., 1988, Biased hypermutation and other genetic changes in defective measles viruses in human brain infection, Cell 55: 255–266.PubMedGoogle Scholar
  44. 44.
    Cattaneo, R., Schmid, A., Billeter, M. A., Sheppard, R. D., and Udem, S. A., 1988, Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line, J. Virol. 62: 1388–1397.PubMedGoogle Scholar
  45. 45.
    Kristensson, K., Örvell, C., Leestma, J., and Norrby, E., 1983, Sendai virus infection in the brains of mice: Distribution of viral antigens studied with monoclonal antibodies, J. Infect. Dis. 147: 297–301.Google Scholar
  46. 46.
    Kristensson, K., Örvell, C., Malm, M., and Norrby, E., 1984, Mumps virus infection of the developing mouse brain. Appearance of structural virus proteins demonstrated with monoclonal antibodies, J Neuropathol. Exp. Neurol. 43: 131–140.PubMedGoogle Scholar
  47. 47.
    Löve, A., Andersson, T., Norrby, E., and Kristensson, K., 1987, Mumps virus infection of dissociated rodent spinal ganglia in vitro. Expression and disappearance of viral structural proteins from neurons, J. Gen. Virol. 68: 1755–1759.PubMedGoogle Scholar
  48. 48.
    Liebert, U. G., and ter Meulen, V., 1987, Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats, J. Gen. Virol. 68: 1715–1722.PubMedGoogle Scholar
  49. 49.
    Love, A., Norrby, E., and Kristensson, K., 1986, Measles encephalitis in rodents: Defective expression of viral proteins, J. Neuropathol. Exp. Neurol. 45: 258–267.PubMedGoogle Scholar
  50. 50.
    Forsberg, P., Fryden, A., Link, H., and Örvell, C., 1986, Viral IgM and IgG antibody synthesis within the central nervous system in mumps meningitis, Acta Neurol. Scand. 73: 372–380.PubMedGoogle Scholar
  51. 51.
    Ukkonen, P., Granström, M.-L., Räsänen, J., Salonen, E.-M., and Penttinen, K., 1981, Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients, J Med. Virol. 8: 257–265.Google Scholar
  52. 52.
    Chiodi, E, Sundqvist, V.-A., Norrby, E., Mavra, M., and Link, H., 1986, Measles IgM antibodies in cerebrospinal fluid and serum in subacute sclerosing panencephalitis, J. Med. Virol. 18: 149–158.Google Scholar
  53. 53.
    Lowenthal, A., Van Sande, M., and Karcher, D., 1960, The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma globulins, J. Neurochem. 6: 51–56.Google Scholar
  54. 54.
    Link, H., Panelius, M., and Salmi, A. A., 1972, Measles antibodies and immunoglobulins in serum and cerebrospinal fluid in subacute sclerosing panencephalitis, Acta Neurol. Scand. [Suppl.J 51: 385–387.Google Scholar
  55. 55.
    Vandvik, B., and Norrby, E., 1973, Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis, Proc. Natl. Acad. Sci. U.S.A. 70: 1060–1063.PubMedGoogle Scholar
  56. 56.
    Fryden, A., Link, H., and Norrby, E., 1978, Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology, Infect. Immun. 21: 852–861.Google Scholar
  57. 57.
    Link, H., Laurenzi, M. A., and Fryden, A., 1981, Viral antibodies in oligoclonal and polyclonal IgG synthesized within the central nervous system over the course of mumps meningitis, J. Neuroimmunol. 1: 287–298.PubMedGoogle Scholar
  58. 58.
    Vandvik, B., Nilsen, R. E., Vartdal, E, and Norrby, E., 1982, Mumps meningitis: Specific and nonspecific antibody responses in the central nervous system, Acta Neurol. Scand. 65: 468–487.PubMedGoogle Scholar
  59. 59.
    Norrby, E., Örvell, C., Vandvik, B., and Cherry, J. D., 1981, Antibodies against measles virus polypeptides in different disease conditions, Infect. Immun. 34: 718–724.PubMedGoogle Scholar
  60. 60.
    Dhib-Jalbut, S., McFarland, H. E, Mingioli, E. S., Sever, J. S., and McFarlin, D. E., 1988, Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panancephalitis, J. Virol. 62: 2483–2489.PubMedGoogle Scholar
  61. 61.
    Hall, W. W, Lamb, R., and Choppin, P. W, 1979, Measles and subacute sclerosing panencephalitis virus proteins: Lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis, Proc. Natl. Acad. Sci. U.S.A. 76: 2047–2051.PubMedGoogle Scholar
  62. 62.
    Wechsler, S. L., Weiner, H. L., and Fields, B. N., 1979, Immune response in subacute sclerosing panencephalitis: Reduced antibody response to the matrix protein of measles virus, J. Immunol. 123: 884–889.PubMedGoogle Scholar
  63. 63.
    Stephenson, J. R., and ter Meulen, V., 1979, Antigenic relationship between measles and canine distemper virus: Comparison of immune response in animals and humans to individual virus-specific polypeptides, Proc. Natl. Acad. Sci. U.S.A. 76: 6601–6605.PubMedGoogle Scholar
  64. 64.
    Rima, B. K., Baczko, K., Imagawa, D. T., and ter Meulen, V, 1987, Humoral immune response in dogs with old dog encephalitis and chronic distemper meningo-encephalitis, J. Gen. Virol. 68: 1723–1735.PubMedGoogle Scholar
  65. 65.
    Vaheri, A., Julkunen, J., and Koskiniemi, M.-L., 1982, Chronic encephalomyelitis with specific increase in intrathecal mumps antibodies, Lancet 25: 685–689.Google Scholar
  66. 66.
    Ilonen, J., Reunanen, M., Herva, G., Ziola, B., and Salmi, A., 1980, Stimulation of lymphocytes from subacute sclerosing panancephalitits patients by defined measles anti-gens, Cell. Immunol. 51: 201–214.PubMedGoogle Scholar
  67. 67.
    Shek, W. R., Schultz, R. D., and Appel, M. J. G., 1980, Natural and immune cytolysis of canine distemper virus-infected target cells, Infect. Immun. 28: 724–734.PubMedGoogle Scholar
  68. 68.
    Frydén, A., Link, H., and Willer, E., 1978, Demonstration of cerebrospinal fluid lymphocytes sensitized against virus antigens in mumps meningitis, Acta Neurol. Scand. 57: 396–404.PubMedGoogle Scholar
  69. 69.
    Kam-Hansen, S., Frydén, A., and Link, H., 1978, B and T lymphocytes in cerebrospinal fluid and blood in multiple sclerosis, optic neuritis and mumps meningitis, Acta Neurol. Scand. 58: 95–103.PubMedGoogle Scholar
  70. 70.
    Kreth, H. W, Kress, L., Kress, H. G., Ott, H. E, and Eckert, G., 1982, Demonstration of primary cytotoxic T cells in venous blood and cerebrospinal fluid of children with mumps meningitis, J Immunol. 128: 2411–2415.PubMedGoogle Scholar
  71. 71.
    Reunanen, M., Salonen, R., and Salmi, A., 1982, Intrathecal immune responses in mumps meningitis patients, Scand, J. Immunol. 15: 419–426.Google Scholar
  72. 72.
    Fleischer, B., and Kreth, H. W, 1983, Clonal analysis of HLA restricted virus specific cytotoxic T-lymphocytes from cerebrospinal fluid in mumps meningitis, J. Immunol. 130: 2187–2190.PubMedGoogle Scholar
  73. 73.
    Nagai, H., Morishima, T., Morishima, Y., Isomura, S., and Suzuki, S., 1983, Local T subsets in mumps meningitis, Arch. Dis. Child. 11: 927–928.Google Scholar
  74. 74.
    Rydbeck, R., Löve, A., Örvell, C., and Norrby, E., 1986, Antigenic variations of envelope and internal proteins of mumps virus strains detected with monoclonal antibodies, J. Gen. Virol. 67: 281–287.PubMedGoogle Scholar
  75. 75.
    Vandvik, B., Norrby, E., Steen Johnson, J., and Stensvold, K., 1978, Mumps meningitis: Prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid, Eur. Neurol. 17: 13–22.Google Scholar
  76. 76.
    Timmons, G. D., and Johnson, K. P., 1970, Aqueductal stenosis and hydrocephalus after mumps encephalitis, N. Engl. J. Med. 283: 1505–1507.PubMedGoogle Scholar
  77. 77.
    Wolinsky, J. S., and Stroop, W. G., 1978, Virulence and persistence of three prototype strains of mumps virus in newborn hamsters, Arch. Virol. 57: 355–359.PubMedGoogle Scholar
  78. 78.
    McCarthy, M., Jubelt, B., Fay, D. B., and Johnson, R. T., 1980, Comparative studies of five strains of mumps virus in vitro and in neonatal hamsters: Evaluation of growth, cytopathogenicity and neurovirulence, J Med. Virol. 5: 1–15.PubMedGoogle Scholar
  79. 79.
    Löve, A., Malm, G., Rydbeck, R., Norrby, E., and Kristensson, K., 1985, Developmental disturbances in the hamster retina caused by a mutant of mumps virus, Dev. Neurosci. 7: 65–72.PubMedGoogle Scholar
  80. 80.
    Merz, D. C., and Wolinsky, J. S., 1981, Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity, Virology 114: 218–227.PubMedGoogle Scholar
  81. 81.
    Merz, D. C., and Wolinsky, J. S., 1983, Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN protein, Virology 131: 328–340.PubMedGoogle Scholar
  82. 82.
    Wolinsky, J. S., Waxham, M. N., and Server, A. C., 1985, Protective effects of glycoproteinspecific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis, J. Virol. 53: 727–734.PubMedGoogle Scholar
  83. 83.
    Löve, A., Rydbeck, R., Utter, G., Örvell, C., Kristensson, K., and Norrby, E., 1986, Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis, J. Virol. 58: 220–222.PubMedGoogle Scholar
  84. 84.
    Frank, J. A., Warren, R. W, Tucker, A., Zeller, J., and Wilfert, C. M., 1983, Disseminated parainfluenza infection in a child with severe combined immunodeficiency, Am. J. Infect. Dis. 137: 1172–1174.Google Scholar
  85. 85.
    Shimokata, K., Nishiyama, Y., Ito, Y., Kimura, Y., Nagata, I., Iida, M., and Sobue, I., 1976, Pathogenesis of Sendai virus infection in the central nervous system of mice, Infect. Immun. 13: 1497–1502.PubMedGoogle Scholar
  86. 86.
    Schwendemann, G., and Löhler, J., 1979, Pathological alterations of ependyma and choroid plexus after experimental cerebral infection of mice with Sendai virus, Acta Neuropathol. (Berl.) 46: 85–94.Google Scholar
  87. 87.
    Kristensson, K., Leestma, J., Lundh, B., and Norrby, E., 1984, Sendai virus infection in the mouse brain: Virus spread and long-term effects, Acta Neuropathol. (Berl.) 63: 89–95.Google Scholar
  88. 88.
    Rorke, L. B., Gilden, D. H., Wroblewska, Z., and Wolinsky, J. S., 1976, Experimental panencephalitis induced in suckling mice by parainfluenza type 1 (6/94) virus. I. Clinical and pathological features, J. Neuropathol. Exp. Neurol. 35: 247–258.PubMedGoogle Scholar
  89. 89.
    Gilden, D. H., Wroblewska, Z., Chesler, M., Wellish, M. C., Lief, E. S., Wolinsky, J. S., and Rorke, L. B., 1976, Experimental panencephalitis induced in suckling mice by para-influenza type 1 (6/94) virus, J. Neuropathol. Exp. Neurol. 35:259–270.Google Scholar
  90. 90.
    Wolinsky, J. S., Gilden, D. H., and Rorke, L. B., 1976, Experimental panencephalitis induced in suckling mice by parainfluenza I (6/94) virus, J. Neuropathol. Exp. Neurol. 35: 271–286.PubMedGoogle Scholar
  91. 91.
    Zgorniak-Nowosielska, I., Iwasaki, Y., Tachovsky, T, Tanaka, R., and Koprowski, H., 1976, Experimental parainfluenza type 1 virus-induced encephalopathy in adult mice. Pathogenesis of chronic degenerative changes in the CNS, Arch. Neurol. 33: 55–62.PubMedGoogle Scholar
  92. 92.
    Koch, E. M., Neubert, W. J., and Hofschneider, P. H., 1984, Lifelong persistence of paramyxovirus Sendai-6/94 in C129 mice: Detection of a latent viral RNA by hybridization with a cloned genomic cDNA probe, Virology 136: 78–88.PubMedGoogle Scholar
  93. 93.
    Shibuta, H., Adachi, A., Kanda, T, and Shimada, H., 1978, Experimental parainfluenzavirus infection. I. Hydrocephalus of mice due to infection with parainfluenza virus type 1 and type 3, Microbiol. Immunol. 22: 505–508.PubMedGoogle Scholar
  94. 94.
    Shibuta, H., Adachi, A., Kanda, T., and Matumoto, M., 1982, Experimental parainfluenzavirus infection in mice: Fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus, Infect. Immun. 35: 437–441.PubMedGoogle Scholar
  95. 95.
    Shibuta, H., Kanda, T., Nozawa, A., Sato, S., and Kumanishi, T., 1985, Experimental parainfluenza virus infection in mice: Growth and spread of a highly pathogenic variant of parainfluenza 3 virus in the mouse brain, Arch. Virol. 83: 43–52.PubMedGoogle Scholar
  96. 96.
    Rydbeck, R., Löve, A., Örvell, C., and Norrby, E., 1987, Antigenic analysis of human and bovine parainfluenza virus type 3 strains with monoclonal antibodies, J. Gen. Virol. 68: 2153–2160.PubMedGoogle Scholar
  97. 97.
    Baumgärtner, W, Metzler, A. E., Krakowka, S., and Koestner, A., 1981, In vitro identification and characterization of a virus isolated from a dog with neurological dysfunction, Infect. Immun. 31: 1177–1183.Google Scholar
  98. 98.
    Evermann, J. E, Krakowa, S., McKeirnan, A. J., and Baumgärtner, W, 1981, Properties of an encephalitogenic canine parainfluenza virus, Arch. Virol. 68: 165–172.Google Scholar
  99. 99.
    Baumgärtner, W, Krakowa, S., Koestner, A., and Evermann, J., 1982, Acute encephalitis and hydrocephalus in dogs caused by canine parainfluenza virus, Vet. Pathol. 19: 79–92.PubMedGoogle Scholar
  100. 100.
    Sheshberadaran, H., Chen, S.-N., and Norrby, E., 1983, Monoclonal antibodies against five structural components of measles virus, Virology 128: 341–353.PubMedGoogle Scholar
  101. 101.
    Johnson, R. T., Griffin, D. E., Hirsch, R., and Vaisberg, A., 1983, Measles encephalitis, Clin. Exp. Neurol. 19: 13–16.PubMedGoogle Scholar
  102. 102.
    Gendelman, H. E., Wolinsky, J. S., Johnson, R. T., Pressman, N. J., Pezeshkpour, G. H., and Boisset, G. E, 1984, Measles encephalomyelitis: Lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination, Ann. Neurol. 15: 353–360.PubMedGoogle Scholar
  103. 103.
    Kipps, A., Dick, G., and Moodie, J. W, 1983, Measles and the central nervous system, Lancet 17: 1406–1410.Google Scholar
  104. 104.
    Sever, J. L., 1983, Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis, Rev. Infect. Dis. 5: 467–473.PubMedGoogle Scholar
  105. 105.
    Graves, M. C., 1984, Subacute sclerosing panencephalitis, Neurol. Clin. 2: 267–280.PubMedGoogle Scholar
  106. 106.
    Horta-Barbosa, L., Fuccillo, D. A., London, W. J., Jabbour, J. T., Zeman, W, and Sever, J. L., 1969, Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis, Proc. Soc. Exp. Biol. Med. 132: 272–277.PubMedGoogle Scholar
  107. 107.
    Budka, H., Lassmann, H., and Popow-Kraupp, T., 1982, Measles virus antigen in pan-encephalitis. An immunomorphological study stressing dendritic involvement in SSPE, Acta Neuropathol. (Berl.) 56: 52–62.Google Scholar
  108. 108.
    Dowling, P. C., Blumberg, B. M., Kolakofsky, D., Cook, P., Jotkowitz, A., Prineas, J. W, and Cook, S. D., 1986, Measles virus nucleic acid sequences in human brain, Virus Res. 5: 97–107.PubMedGoogle Scholar
  109. 109.
    Thormar, H., Metha, P. D., Barshatzky, M. R., and Brown, H. R., 1985, Measles virus encephalitis in ferrets as a model for subacute sclerosing panencephalitis, Lab. Animal Sci. 35: 229–232.Google Scholar
  110. 110.
    Thormar, H., Metha, P. D., Barshatzky, M. R., and Brown, H. R., 1985, Localization of measles virus antigens in subacute sclerosing panencephalitis in ferrets, Lab. Anim. Sci. 35: 233–237.PubMedGoogle Scholar
  111. 111.
    Brown, H. R., Pessolano, T. L., Nostro, A. F., and Thormar, H., 1985, Demonstration of immunoglobulin in brains of ferrets inoculated with a SSPE strain of measles virus: Use of protein A conjugated to horseradish peroxidase, Acta Neuropathol. (Berl.) 65: 195–201.Google Scholar
  112. 112.
    Roos, R. P., Griffin, D. E., and Johnson, R. T., 1978, Determinants of measles virus (hamster neurotropic strain) replication in mouse brain, J. Infect. Dis. 137: 722–727.PubMedGoogle Scholar
  113. 113.
    Norrby, E., and Kristensson, K., 1978, Subacute encephalitis and hydrocephalus in hamsters caused by measles virus from persistently infected cell cultures, J. Med. Virol. 2: 305–317.PubMedGoogle Scholar
  114. 114.
    Johnson, K. P., and Swoveland, P., 1977, Measles antigen distribution in brains of chronically infected hamsters. An immunoperoxidase study of experimental subacute sclerosing panencephalitis, Lab. Invest. 37: 459–465.PubMedGoogle Scholar
  115. 115.
    Cremer, N. E., Hagens, S. J., Taylor, D. O. N., and Lennette, E. H., 1977, Complications and immunological studies of measles virus in antithymocyte-treated hamsters, Infect. Immun. 16: 155–162.PubMedGoogle Scholar
  116. 116.
    Thormar, H., Arnesen, K., and Mehta, P. D., 1977, Encephalitis in ferrets caused by a nonproductive strain of measles virus (D.R.) isolated from a patient with subacute sclerosing panencephalitis, J. Infect. Dis. 136: 229–238.PubMedGoogle Scholar
  117. 117.
    Albrecht, P., Burnstein, T., Klutch, M. J., Hicks, J. T., and Ennis, F. A., 1977, Subacute sclerosing panencephalitis: Experimental infection in primates, Science 195: 64–66.Google Scholar
  118. 118.
    Sharova, O. K., Bomologova, N. N., Koptyaeva, I. B., Gordienko, N. M., and Rozina, E. E., 1987, Pathomorphologic characterization of CNS damage in monkeys infected with a persistent variant of measles virus vaccine strain L-16, Acta Virol. 31; 336–351.Google Scholar
  119. 119.
    Giraudon, P., and Wild, T. F., 1985, Correlation between epitopes on hemagglutinin of measles virus and biological activities: Passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity, Virology 144: 46–58.PubMedGoogle Scholar
  120. 120.
    Örvell, C., Sheshberadaran, H., and Norrby, E., 1985, Preparation and characterization of monoclonal antibodies directed against four structural components of canine distemper virus, J Gen. Virol. 66:443–456’Google Scholar
  121. 121.
    Bollo, E., Zurbriggen, A., Vandevelde, M., and Frankhauser, R., 1986, Canine distemper virus clearance in chronic inflammatory demyelination, Acta Neuropathol. (Berl.) 72: 69–73.Google Scholar
  122. 122.
    Kimoto, T., 1986, In vitro and in vivo properties of the virus causing natural canine distemper encephalitis, J. Gen. Virol. 67: 487–503.Google Scholar
  123. 123.
    Vandevelde, M., and Kristensen, B., 1977, Observations on the distribution of canine distemper virus in the central nervous system of dogs with demyelinating encephalitis, Acta Neuropathol. (Berl.) 40: 233–236.Google Scholar
  124. 124.
    Vandevelde, M., Zurbriggen, A., Higgins, R. J., and Palmer, D., 1985, Spread and distribution of viral antigen in nervous canine distemper virus, Acta Neuropathol. (Berl.) 67: 211–218.Google Scholar
  125. 125.
    McCullough, B., Krakowa, S., Koestner, A., and Shadduk, J., 1974, Demyelinating activity of canine distemper virus isolates in gnotobiotic dogs, J. Infect. Dis. 130: 343–350.PubMedGoogle Scholar
  126. 126.
    Lyons, M. J., Hall, W. W, Petito, C., Cam, V., and Zabriskie, J. B., 1980, Induction of chronic neurologic disease in mice with canine distemper virus, Neurology 30: 92–98.PubMedGoogle Scholar
  127. 127.
    Gilden, D. H., Wellish, M., Rorke, L. B., and Wroblewska, Z., 1981, Canine distemper virus infection in weanling mice. Pathogenesis of CNS disease, J. Neurol. Sci. 52: 327–339.PubMedGoogle Scholar
  128. 128.
    Bernard, A., Wild, T. E, and Tripier, M. E, 1983, Canine distemper infection in mice: Characterization of a neuro-adapted virus strain and its long-term evolution in the mouse, J. Gen. Virol. 64: 1571–1579.PubMedGoogle Scholar
  129. 129.
    Vandelvelde, M., Zurbriggen, A., Dumas, M., and Palmer, D., 1985, Canine distemper virus does not infect oligodendrocytes in vitro, J. Neurol. Sci. 69: 133–137.Google Scholar
  130. 130.
    Zurbriggen, A., Vandevelde, M., and Dumas, M., 1986, Secondary degeneration of oligodendrocytes in canine distemper virus infection in vitro, Lab. Invest. 54: 424–431.PubMedGoogle Scholar
  131. 131.
    Zurbriggen, A., Vandevelde, M., Dumas, M., Griot, C., and Bollo, E., 1987, Oligodendroglial pathology in canine distemper virus infection in vitro, Acta Neuropathol. (Berl.) 74: 366373.Google Scholar
  132. 132.
    Nishikawa, K., Isomura, S., Suzuki, S, Watanabe, E., Hamaguchi, M., Yoshida, T., and Nagai, Y., 1983, Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparison, Virology 130: 318–330.PubMedGoogle Scholar
  133. 133.
    Stevens, J. G., Nakamura, R. M., Cook, M. L., and Wilczynski, S. P., 1976, Newcastle disease as a model for paramyxovirus-induced neurological syndromes: Pathogenesis of the respiratory disease and preliminary characterization of the ensuing encephalitis, Infect. Immun. 13: 590–599.PubMedGoogle Scholar
  134. 134.
    Burks, J. S., Narayan, O., McFarland, H. E, and Johnson, R. T., 1976, Acute encephalopathy caused by defective virus infection. I. Studies of Newcastle disease virus infections in newborn and adult mice, Neurology 26: 584–588.PubMedGoogle Scholar
  135. 135.
    Nagai, Y., Klenk, H.-D., and Rott, R., 1976, Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus, Virology 72: 494–508.PubMedGoogle Scholar
  136. 136.
    Scheid, A., and Choppin, P. W, 1974, Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus, Virology 57: 475–490.PubMedGoogle Scholar
  137. 137.
    Roos, R. P., and Wollman, R., 1979, Non-productive paramyxovirus infection: Nariva virus infection in hamsters, Arch. Virol. 62: 229–240.PubMedGoogle Scholar
  138. 138.
    Moreno-López, J., Correa-Giron, P., Martinez, A., and Ericsson, A., 1986, Characterization of a paramyxovirus isolated from the brain of a piglet in Mexico, Arch. Virol. 91: 221–231.PubMedGoogle Scholar
  139. 139.
    Bachmann, P. A., ter Meulen, V., Jentsch, G., Appel, M., Iwasaki, Y., Meyermann, R., Koprowski, H., and Mayr, A., 1975, Sporadic bovine meningoencephalitis—isolation of a paramyxovirus, Arch. Virol. 48: 107–120.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1992

Authors and Affiliations

  • Claes Örvell
    • 1
  1. 1.Department of Virology, National Bacteriological Laboratory and Karolinska InstituteSchool of MedicineStockholmSweden

Personalised recommendations